SEC Form 4 · accession 0001144204-18-038033
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
BFI Co., LLC
10% Owner
Period of report
Jul 9, 2018
Accepted (ET)
Jul 11, 2018 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Jul 9, 2018 | C | 30,000 | $0.00 | A | 60,000 | D | |
| Class A Common StockF2,F3 | Jul 9, 2018 | S | 10,000 | $46.96 | D | 50,000 | D | |
| Class A Common StockF2,F4 | Jul 10, 2018 | S | 10,000 | $46.81 | D | 40,000 | D | |
| Class A Common StockF2,F5 | Jul 11, 2018 | S | 10,000 | $46.89 | D | 30,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common StockF1,F2 | $0.00 | Jul 9, 2018 | C | 30,000 | D | — | — | Class A Common Stock | 30,000 | 20,335,504 | D |
Explanation of responses
- F1Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis and has no expiration date.
- F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.70 to $47.35, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.25, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.45 to $47.20, inclusive.